According to the official, nine international unpatented medicines against hypertension will be sold at referent prices. "Such measures will let seven million people suffering hypertension to save about 200 million hryvnias annually," he explained.
Solovyov added that it is also planned to continue this pilot project and to introduce referent prices for other medicines.
